About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
exaly
›
Institutions
›
Mayo Clinic
›
Division of Hematology
›
Top Articles
Division of Hematology
Mayo Clinic
8.1K
Articles
237.5K
Citations
3.1
avg. Impact Factor
199
h-index
Most Cited Articles of Division of Hematology in 2014
Title
Journal
Year
Citations
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
Lancet Oncology, The
2014
2.3K
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
Leukemia
2014
880
Intervention to promote physician well-being, job satisfaction, and professionalism: a randomized clinical trial
JAMA Internal Medicine
2014
434
Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis
Blood
2014
424
IMWG consensus on risk stratification in multiple myeloma
Leukemia
2014
387
CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons
Leukemia
2014
381
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes
Blood
2014
294
International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation
Journal of Clinical Oncology
2014
255
Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma
PLoS Genetics
2014
239
Biomedical system dynamics to improve anemia control with darbepoetin alfa in long-term hemodialysis patients
Mayo Clinic Proceedings
2014
234
Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer
Journal of the National Cancer Institute
2014
215
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients
Leukemia
2014
213
Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction
JACC: Heart Failure
2014
212
CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients
Leukemia
2014
211
Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study
Lancet Oncology, The
2014
207
Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia
Blood
2014
202
Remission of disseminated cancer after systemic oncolytic virotherapy
Mayo Clinic Proceedings
2014
202
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project
Journal of the National Cancer Institute Monographs
2014
199
ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients
Leukemia
2014
186
DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies
Leukemia
2014
184
The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases
Leukemia
2014
179
New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)
Leukemia
2014
179
Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma
Human Pathology
2014
179
Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis
Mayo Clinic Proceedings
2014
173
Phase 1 study of weekly dosing with the investigational oral proteasome inhibitor ixazomib in relapsed/refractory multiple myeloma
Blood
2014
169
Schools/Departments
The list of schools/departments is not comprehensive since it is common to drop the department in the affiliation.
site/software ©
exaly
; All materials licenced under
CC by-SA
.